Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Post by Schaffhausenon Oct 06, 2020 7:04am
310 Views
Post# 31672094

VIVO management 12-month forecast, Oct.1 2020-Oct.1 2021

VIVO management 12-month forecast, Oct.1 2020-Oct.1 2021Management says:  "On the basis of the foregoing, and taking into account its expected revenues for the noted 12-month period, the Company expects to be able to continue operations using it's currently available non-contingent resources for at least the next 12 months."


The following is the copied excerpt showing twelve month costs estimated at $49M.  Management confirms no other planned capital expenditures.  If you look at Quarter over Quarter revenue growth it already points to revenue that will exceed these costs, likley significantly.  

 






Cheers,

Schaff

<< Previous
Bullboard Posts
Next >>